Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: Potential and technical improvements

Clinical Chemistry

Volumn 54, Issue 4, 2008, Pages 688-696

  Müller, Imke ^a   Beeger, Cord ^a   Alix Panabières, Catherine ^b   Rebillard, Xavier ^c   Pantel, Klaus ^a   Schwarzenbach, Heidi ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LAPEYRONIE HOSPITAL   (France)

^c Beau Soleil Clinic   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TETRAMETHYLAMMONIUM CHLORIDE; MICROSATELLITE DNA;

ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PROSTATE CANCER; BLOOD; FLUORESCENCE; GENETICS; PATHOLOGY; PROSTATE TUMOR;

DNA; FLUORESCENCE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 42449150834     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.099333     Document Type: Article

References (38)

1. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids: a promising, non-invasive tool for early detection of several human diseases. FEBS Lett 2007;581:795-9.
2. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer: a survey. Biochim Biophys Acta 2007;1775:181-232.
3. Fujiwara Y, Chi DD, Wang H, Keleman P, Morton DL, Turner R, Hoon DS. Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res 1999;59:1567-71.
4. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996;2:1035-7.
5. Wachowiak R, Kaifi JT, Schurr PG, Merkert P, Yekebas E, Schwarzenbach H, et al. Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis. Anticancer Res 2007;27:477-81.
6. Schwarzenbach H, Müller V, Stahmann N, Pantel K. Detection and characterisation of circulating microsatellite-DNA in blood of patients with breast cancer. Circulating Nucleic Acids in Plasma/Serum Proteomics III. Ann N Y Acad Sci 2004;1022:25-32.
7. Müller I, Urban K, Pantel K, Schwarzenbach H. Comparison of genetic alterations detected in circulating microsatellite-DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia. Circulating Nucleic Acids in Plasma/Serum and Serum Proteomics IV. Ann N Y Acad Sci 2006;1075:222-9.
8. Schwarzenbach H, Chun FK, Lange I, Carpenter S, Gottberg M, Erbersdobler A, et al. Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer. Int J Cancer 2007;120:1465-71.
9. Schwarzenbach H, Müller V, Beeger C, Gottberg M, Stahmann N, Pantel K. A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer. Breast Cancer Res 2007;9:R66.
10. Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 1998;14:272-6.
11. Farrand K, Jovanovic L, Delahunt B, McIver B, Hay ID, Eberhardt NL, Grebe SK. Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn 2002;4:150-8.
12. Coombs NJ, Gough AC, Primrose JN. Optimization of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res 1999;27:12.
13. Baisse B, Bian YS, Benhattar J. Microdissection by exclusion and DNA extraction for multiple PCR analysis from archival tissue sections. Biotechniques 2000;28:856-62.
14. Greer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin-embedded tissues: effects of fixative and fixation time. Am J Clin Pathol 1991;95:117-24.
15. Charames GS, Bapat B. Genomic instability and cancer. Curr Mol Med 2003;3:589-96.
16. Stroun M, Anker P, Lyautey J, Lederrey C, Maurice PA. Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 1987;23:707-12.
17. Bruhn N, Beinert T, Oehm C, Jandrig B, Petersen I, Chen XQ, et al. Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer. Ann N Y Acad Sci 2000;906:72-82.
18. Chen XQ, Bonnefoi H, Diebold-Berger S, Lyautey J, Lederrey C, Faltin-Traub E, et al. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 1999;5:2297-303.
19. Coulet F, Blons H, Cabelguenne A, Lecomte T, Laccourreye O, Brasnu D, et al. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res 2000;60:707-11.
20. Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D, Jen J. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 1998;58:1405-7.
21. Kopreski MS, Benko FA, Kwee C, Leitzel KE, Eskander E, Lipton A, Gocke CD. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br J Cancer 1997;76:1293-9.
22. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61:1659-65.
23. Choi JJ, Reich CF 3rd, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 2005;115:55-62.
24. Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A 2005;102:16368-73.
25. Tidow N, Boecker A, Schmidt H, Agelopoulos K, Boecker W, Buerger H, Brandt B. Distinct amplification of an untranslated regulatory sequence in the EGFR gene contributes to early steps in breast cancer development. Cancer Res 2003;63:1172-8.
26. Wang M, Block TM, Steel L, Brenner DE, Su YH. Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA. Clin Chem 2004;50:211-3.
27. Hung T, Mak K, Fong K. A specificity enhancer for polymerase chain reaction. Nucleic Acids Res 1990;18:4953.
28. Chevet E, Lemaitre G, Katinka MD. Low concentrations of tetramethylammonium chloride increase and specificity of PCR. Nucleic Acids Res 1995;23:3343-4.
29. Chun FK, Müller I, Lange I, Friedrich MG, Erbersdobler A, Karakiewicz PI, et al. Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer. BJU Int 2006;98:544-8.
30. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-5.
31. Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997;112:1114-20.
32. Anker P, Mulcahy H, Chen XQ, Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999;18:65-73.
33. Bremnes RM, Sirera R, Camps C. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 2005;49:1-12.
34. Wang Q, Larson PS, Schlechter BL, Zahid N, Finnemore E, de las Morenas A, et al. Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer. Int J Cancer 2003;106:923-9.
35. Bonkhoff H, Remberger K. Morphogenetic concepts of normal and abnormal growth in the human prostate. Virchows Arch 1998;433:195-202.
36. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 1998;17:89-97.
37. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Török L, Ellinger A, Müllauer L. Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol Lett 1995;82:143-8.
38. Hata N, Yoshimoto K, Yokoyama N, Mizoguchi M, Shono T, Guan Y, et al. Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis. Clin Chem 2006;52:370-8.